{"id":"W4387775935","doi":"10.51731/cjht.2023.752","title":"Semaglutide for Type 2 Diabetes (2 mg)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Discontinuation; Medicine; Placebo; Adverse effect; Diabetes mellitus; Type 2 diabetes; Glycemic; Internal medicine; Randomized controlled trial; Dulaglutide; Endocrinology; Exenatide; Alternative medicine; Liraglutide","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004613665,0.00009061225,0.0003135265,0.0007654874,0.0001281829,0.00001643344,0.0001341347,0.00006771893,0.0000136412],"category_scores_gemma":[0.0006141838,0.00007171415,0.00007784876,0.0004906537,0.00007885141,0.00003759493,0.00001429503,0.0001218002,0.00003120875],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002261185,"about_ca_system_score_gemma":0.0009359679,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001648111,"about_ca_topic_score_gemma":0.000438952,"domain_scores_codex":[0.9990169,0.00001049113,0.0002979579,0.00009194249,0.00008974682,0.0004929416],"domain_scores_gemma":[0.9993674,0.00007395948,0.0001588949,0.0001691786,0.000136449,0.00009419148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001273326,0.00001899423,0.03479262,0.0004135417,0.0002083953,0.0001021427,0.0001001236,0.000007596346,0.00007697233,0.001787118,0.1719262,0.7905536],"study_design_scores_gemma":[0.0009757247,0.001729686,0.0321788,0.0003566977,0.00007732735,0.00001284724,0.001412528,0.00004271232,0.0008190997,0.004826777,0.9574601,0.0001077231],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8035866,0.04173328,0.00003971764,0.1517453,0.001068135,0.0008770733,0.00002456927,0.0004435708,0.0004817636],"genre_scores_gemma":[0.9965174,0.0005622598,0.001064282,0.0008139654,0.00002211291,0.00001536954,0.00001310306,0.00001794094,0.0009735683],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7904459,"threshold_uncertainty_score":0.2924418,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05726240410101599,"score_gpt":0.3232356622110811,"score_spread":0.2659732581100651,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}